In a phase III study presented by Shukui Qin, the combination of #immunotherapy plus an anti-angiogenic TKI showed effectiveness as...

The addition of #brentuximab_vedotin shows survival benefits in patients with previously untreated stage III or IV classic #Hodgkin’s_lymphoma. The ECHELON-1...

In the Chinese phase III, DAWNA-2 study presented by Xu el al, the addition of the CDK 4/6 inhibitor #Dalbiciclib...

In the Japanese JCOG0905 study presented by Dr. Hiroaki Hiraga, adding Ifosfamide (IF) to adjuvant chemotherapy in high grade osteosarcoma...

Perioperative #nivolumab did not improve relapse free survival (RFS) in early stage #RCC. This was illustrated in phase III PROSPER...

In the second interim analysis of the phase III MONARCH-3 study, that was presented by Dr Matthew Goetz adding #Abemaciclib...

Adding #pembrolizumab to chemotherapy resulted in significantly longer overall survival among patients with previously untreated advanced #triple_negative_breast_cancer whose tumors expressed...

The FDA has approved #durvalumab (Imfinzi) in combination with gemcitabine and cisplatin in adult patients with locally advanced or metastatic...

In the phase III LEAP-002 study presented by Richard Finn, adding pembrolizumab to first line #Lenvatinib in HCC patients improved...

Patients with cancer often suffer shortness of breath for different reasons. Many physicians prescribe empirical dexamethasone as a symptomatic treatment....